Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-sequence on prostates of wild type (C57BL/6J) and ARNoC/Y mice that underwent orchidectomy and testosterone (or vehicle) replacement for 4 days

ABSTRACT: We generated a mouse model (ARNoC/Y) with a mutation in the FQNLF motif located on the aminoterminal domain (NTD) that disrupts the N/C interactions of the androgen receptor (AR). These mice exhibit a normal male phenotype. To be able to compare WT males and ARNoC/Y mice more directly, we performed a castration experiment with testosterone (T) supplementation for 4 days. Since slightly differences in prostate weight were observed, we performed RNA-seq on these prostate to evaluate the biological relevance.

ORGANISM(S): Mus musculus

PROVIDER: GSE207582 | GEO | 2022/08/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-sequence on kidneys of wild type C57BL/6J and ARLmon/Y mice that underwent orchidectomy and testosterone (or vehicle) replacement for 4 days

Project description:We generated a mouse model (ARLmon/Y) with disrupted dimerization of the ligand-binding domain 25 (LBD) of the androgen receptor (AR). These mice exhibit an external female phenotype with undescended testes. Histological analysis of the testes of ARLmon/Y mice revealed some residual spermatogenesis. Hormone measurements in serum of the ARLmon/Y mice showed significantly high levels of androgens. To study if there is any remaining AR activity, we orchidectomized WT and ARLmon/Y mice and gave them supraphysiological testosterone replacement for 4 days. RNA-seq was performed on kindeys.

2021-08-23 | GSE172020 | GEO

Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer Patients

Project description:With increasing age and the additional impact from the bowel cancer and the chemotherapy and/ or radiotherapy it has been described that testosterone (a male hormone produced naturally in the body) levels are reduced. Testosterone has an impact on numerous body functions including the muscle mass and quality. Previous studies have identified that muscle mass is reduced as a result of ageing but also because of the deleterious effect of cancer and chemotherapy and/or radiotherapy. There is growing evidence from published studies that patients with better muscle mass and quality, do better after surgery. Mr Jenkins and his team are therefore looking at ways, the investigators can try and prevent or reduce this muscle loss and therefore improve patient outcomes. The aim of this study is to assess whether using testosterone replacement therapy in the form of a topically applied gel daily for a total of 12 weeks, is feasible and acceptable by the patients who are diagnosed with colorectal cancer and are waiting to undergo surgery. The investigators will also collect information related to the testosterone replacement therapy such as questionnaires on the quality of life, fatigue and muscle mass, and blood biomarker changes in the blood.

| 2729656 | ecrin-mdr-crc

RNA-sequence on prostates of wild type (C57BL/6J) and ARNoC/Y mice that underwent orchidectomy and testosterone (or vehicle) replacement for 4 days

Project description:RNA-sequence on prostates of wild type (C57BL/6J) and ARNoC/Y mice that underwent orchidectomy and testosterone (or vehicle) replacement for 4 days

| PRJNA856265 | ENA

Gene expression profiling in dorsolateral prostates of prepubertal and adult Sprague-Dawley rats dosed with Estradiol Benzoate, Estradiol and Testosterone

Project description:Using rat prostate disease models that Prins and colleagues have developed (Ho et al., 2006 - PMID: 16740699), the purpose of the study is to identify gene(s) for diagnosing early stage of prostate diseases and monitoring the development of prostate diseases. To identify the genes, we analyzed whole genome expression profiling on the prostate from Sprague-Dawley rats dosed postnatally with estradiol benzoate, estradiol and testosterone at PNDs 30, 100 and 145.

2020-08-17 | GSE145917 | GEO

RNA-sequence on kidneys of wild type C57BL/6J and ARLmon/Y mice that underwent orchidectomy and testosterone (or vehicle) replacement for 4 days

Project description:RNA-sequence on kidneys of wild type C57BL/6J and ARLmon/Y mice that underwent orchidectomy and testosterone (or vehicle) replacement for 4 days

| PRJNA721715 | ENA

Transcriptome profile of rat adrenal evoked by gonadectomy and testosterone or estradiol replacement

Project description:Sex differences in rat adrenal cortex are manifested as larger adrenal volume of cortex and higher corticosterone secretion by females compared with males. The molecular bases of these sex related differences are poorly understood. Therefore we performed microarray studies to demonstrate the effect of testosterone and estradiol on the expression of differentially regulated genes in rat adrenal gland.

2017-01-18 | GSE93726 | GEO

Testosterone Replacement versus Placebo Bone and Bone Marrow in Castrated Mice

Project description:Metastatic prostate cancer is commonly localized in bone and treated with androgen ablation, which is initially highly effective, but eventually results in resistant cancer cells. The decreased dependence on androgen is associated with activation of the androgen receptor (AR) via other growth factor receptor pathways. The current study analyzed global gene expression in bone from castrated and sham operated C57BL/6 mice to identify factors that may be responsible for androgen signaling. Androgen suppression by castration increased the expression of 159 genes with insulin-like growth factor binding protein 5 (IGFBP5) being the most consistently increased. IGFBP5 protein was detected by immune histochemistry in osteoblasts, bone marrow stromal cells and endothelial cells. In vitro treatment of marrow stromal cells with charcoal-stripped serum increased IGFBP5 mRNA expression approximately 25-fold and was reversed by androgen supplementation. Endogenous IGFBP5 was incorporated into extracellular matrix. In addition, treatment of extracellular matrices with exogenous IGFBP5 and IGF-1 or IGF-2 enhanced the growth of immortalized human prostate cells. These results suggest that androgen ablative therapy may increase IGFBP5 in the marrow microenvironment, thereby providing support for the development of therapy resistance prostate cancer cells. Keywords: Bone Marrow Environment, Androgen Suppression, IGFBP5, prostate cancer

2007-06-01 | GSE5776 | GEO

Hypogonadal mice and testosterone proprionate treatment

Project description:Analysis of the transcriptome of testes of hypogonadal mice that had been pretreated with testosterone proprionate for 2 weeks then submitted to testosterone withdrawal. Keywords = testis, hypogonadal mice, testosterone Keywords: other

2003-05-28 | GSE438 | GEO

High-throughput Transcriptomic Analysis of Testosterone-Manipulated epididymis

Project description:Androgenic modulation of the structural integrity and functional maintenance of the epididymis have been demonstrated. Androgen receptor is a typical receptor to modulate classical testosterone signaling pathway, while accumulated studies suggested number of membranous receptors or intermediated molecules also involved in testosterone pathway. In RNAseq analysis of castration mouse model, profile of testosterone responsive genes was identified. Comibining with our in-vitro studies, an novel testosterone action which incoperated with glutamine and glutamate transportation has been proposed in epididymal epithlium cells.

2021-01-28 | GSE165602 | GEO

testosterone application induced H3K27 deacetylation

Project description:testosterone application induced H3K27 deacetylation

| PRJNA1137417 | ENA